Pediatric RSV Hospitalizations Increased in 2021 to 2022 Season
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 11, 2023 -- Emerging from the COVID-19 pandemic, respiratory syncytial virus (RSV)-associated hospitalizations in Canadian pediatric hospitals were substantial, particularly among infants younger than 6 months of age, according to a study published online Oct. 4 in JAMA Network Open.
Malou Bourdeau, M.D., from McGill University in Montreal, and colleagues examined the epidemiology and burden of RSV-associated hospitalizations among children and adolescents in Canadian tertiary pediatric hospitals from five RSV seasons (2017 to 2022).
The researchers identified 11,014 RSV-associated hospitalizations, including 23.6 percent that involved admission to the intensive care unit, of which 60.8 percent were among children aged younger than 6 months of age. There were 58 RSV-associated hospitalizations reported in 2020 to 2021 and 3,170 hospitalizations in 2021 to 2022 compared with a mean number of 2,522 hospitalizations during prepandemic seasons. Compared with the prepandemic period, age, sex, intensive care unit admission, prolonged length of stay, and case fatality rate did not change in 2021 to 2022. Regional variation was seen for RSV activity and timing.
"These findings suggest that RSV preventive strategies for infants aged less than 6 months would be associated with decreased RSV disease burden in children," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Further Support and Information on COVID-19
Read this next
Personalized Tool Can Predict Infants at Increased Risk for RSV
THURSDAY, May 9, 2024 -- A personalized tool can predict infants at increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) who would...
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV)...
RSV Burden in Children Under 5 Increased in 2021 and 2022 Versus 2015-2019
FRIDAY, April 19, 2024 -- For children younger than 5 years, the incidence of respiratory syncytial virus (RSV) hospitalization increased in 2021 and 2022 compared with 2015 to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.